Finally, by interrogating available scRNA-seq datasets of tumor-infiltrating immune cells, we reported a significant enrichment of melanoma-infiltrating monocytes/macrophages over-expressing the LXR target genes ABCA1 and SCD1 in ICB-resistant patients. This evidence concerns the gene SCD and melanoma.